Patients with systemic lupus erythematosus have up to a 50-fold increased risk of developing atherosclerotic cardiovascular disease. Recent advances in the etiology of vascular damage in this disease stress the interplay of lupus-specific inflammatory factors with traditional cardiac risk factors, leading to increased endothelial damage. This review analyzes the putative role that immune dysregulation and lupus-specific factors may play in the pathogenesis of premature vascular damage in this disease. The potential role of various cytokines, in particular type I interferons, in the development of accelerated atherosclerosis is examined. Potential therapeutic targets are discussed. © 2011 BioMed Central Ltd.
CITATION STYLE
Kahlenberg, J. M., & Kaplan, M. J. (2011, February 28). The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus. Arthritis Research and Therapy. https://doi.org/10.1186/ar3264
Mendeley helps you to discover research relevant for your work.